Richard A. Larson to Radiotherapy
This is a "connection" page, showing publications Richard A. Larson has written about Radiotherapy.
Connection Strength
0.385
-
Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia. Blood. 1992 Apr 01; 79(7):1892-3.
Score: 0.091
-
Therapy-related myeloid neoplasms. Haematologica. 2009 Apr; 94(4):454-9.
Score: 0.074
-
Therapy-related myeloid leukemia. Semin Oncol. 2008 Aug; 35(4):418-29.
Score: 0.070
-
Myeloid leukemia after cytotoxic therapy and other hematotoxins. J Toxicol Environ Health A. 2000 Nov; 61(5-6):381-6.
Score: 0.041
-
Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 1999 Jul 15; 94(2):803-7.
Score: 0.038
-
Therapy-related myeloid leukemia. Hematol Oncol Clin North Am. 1996 Apr; 10(2):293-320.
Score: 0.030
-
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia. Blood. 1992 Nov 15; 80(10):2463-70.
Score: 0.024
-
Leiomyosarcoma of the scrotum in a man who had received scrotal irradiation as a child. J Urol. 1988 Jan; 139(1):136-8.
Score: 0.017